SILBER ALLAN C reported 1 transaction at POINT BIOPHARMA GLOBAL INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/7/2023ACC: 0001104659-23-115374
Director
Since Jun 2021
-500K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
500K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−500K
Price / share
—
Trade value
—
% of position
92.9%
11/3/2023
538.09K→38.09K
Total
Net shares
−500K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/3/2023 | G · Gift | −500K | — | — | 92.9% | 538.09K | 38.09K |
| Total | −500K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned4.27M
Common Stock
IndirectShares owned4.04M
Common Stock
IndirectShares owned313.88K
Common Stock
IndirectShares owned71.74K
Total
8.69M indirect8.69M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.27M | Indirect |
| Common Stock | 4.04M | Indirect |
| Common Stock | 313.88K | Indirect |
| Common Stock | 71.74K | Indirect |
| Total | 8.69M | 8.69M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported